Puma Biotechnology (PBYI) Debt Ratio (2011 - 2026)

Puma Biotechnology (PBYI) posted Debt Ratio of 0.06 for Q1 2026, down 43.77% on a QoQ basis from 0.1 in Q4 2025, and down 79.48% year-over-year from 0.29 in Q1 2025.

Puma Biotechnology (PBYI) Debt Ratio (2011 - 2026) Analysis & Trends

Puma Biotechnology's Debt Ratio history runs 11 years deep, the most recent figure standing at 0.06 for Q1 2026.

  • Quarterly Debt Ratio fell 79.48% year-over-year to 0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06 (down 79.48% YoY) and the FY2025 annual result came in at 0.1, down 66.87% from the prior year.
  • Debt Ratio was 0.06 for Q1 2026 at Puma Biotechnology, down from 0.1 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.5 in Q2 2022 and bottomed at 0.06 in Q1 2026.
  • A 5-year average of 0.37 and a median of 0.43 in 2024 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio surged 30.97% — and 2026, when it sank 79.48%.
  • Puma Biotechnology's Debt Ratio stood at 0.44 in 2022, then retreated by 2.35% to 0.43 in 2023, then dropped by 27.3% to 0.31 in 2024, then tumbled by 66.87% to 0.1 in 2025, then tumbled by 43.77% to 0.06 in 2026.
  • Business Quant data shows PBYI's Debt Ratio at 0.06 in Q1 2026, 0.1 in Q4 2025, and 0.17 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Puma Biotechnology 407.27 Mn 368.99 Mn 34.39 Mn 0.06

Historic Data

Download Data
DateValue
Mar 31, 2026 0.06
Dec 31, 2025 0.10
Sep 30, 2025 0.17
Jun 30, 2025 0.23
Mar 31, 2025 0.29
Dec 31, 2024 0.31
Sep 30, 2024 0.35
Jun 30, 2024 0.43
Mar 31, 2024 0.47
Dec 31, 2023 0.43
Sep 30, 2023 0.49
Jun 30, 2023 0.49
Mar 31, 2023 0.50
Dec 31, 2022 0.44
Sep 30, 2022 0.49
Jun 30, 2022 0.50
Mar 31, 2022 0.49
Dec 31, 2021 0.43
Sep 30, 2021 0.43
Jun 30, 2021 0.39